Cooperate concept of metastasis: Site-specific requirement of activated differentiation and dynamic deterioration

Cancer and Metastasis Reviews

Volumn 31, Issue 1-2, 2012, Pages 269-276

  Wilmanns, C ^a,b   Steinhauer, S ^a   Grossmann J ^a   Schmitt Graff A ^a   Ruf, G ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Johanniter Krankenhaus   (Germany)

Author keywords

Cadherins; Colonic neoplasms; Gastrointestinal stromal tumors; Individualized medicine; Molecular biology; Neoplasm metastasis; Pathology

Indexed keywords

B RAF KINASE; LYMPHOID ENHANCER FACTOR 1; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN P53; SMAD3 PROTEIN; STAT3 PROTEIN; STEM CELL FACTOR RECEPTOR; UVOMORULIN;

CANCER GRADING; CANCER INVASION; CANCER PATIENT; CELL DEDIFFERENTIATION; COLON CANCER; COLORECTAL CANCER; DROSOPHILA; EPITHELIAL MESENCHYMAL TRANSITION; GASTROINTESTINAL STROMAL TUMOR; GENE ACTIVATION; GENE DELETION; GENE LOSS; GENE MUTATION; GENETIC REGULATION; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; ONCOGENE; PANCREAS CANCER; PERITONEUM METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STOMACH CANCER; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; TUMOR VOLUME;

CADHERINS; CELL DIFFERENTIATION; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; ONCOGENES; PHENOTYPE; SIGNAL TRANSDUCTION;

EID: 84862323792     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-012-9350-3     Document Type: Review

References (71)

1. Poste, G., & Fidler, I. J. (1980). The pathogenesis of cancer metastasis. Nature, 283, 139-146. (Pubitemid 10171124)
2. Fearon, E. R., & Vogelstein, B. (1990). A genetic model for colorectal tumorigenesis. Cell, 61, 759-767.
3. Fidler, I. J., & Kripke, M. L. (1977). Metastasis results from preexisting variant cells within a malignant tumor. Science, 197, 893-895. (Pubitemid 8168759)
4. Fidler, I. J., & Poste, G. (2008). The "seed and soil" hypothesis revisited. The Lancet Oncology, 9, 808.
5. Ramaswamy, S., Ross, K. N., Lander, E. S., & Golub, T. R. (2003). A molecular signature of metastasis in primary solid tumors. Nature Genetics, 33, 49-54. (Pubitemid 36068681)
6. Landemaine, T., Jackson, A., Bellahcène, A., Rucci, N., Sin, S., Abad, B. M., et al. (2008). A six-gene signature predicting breast cancer lung metastasis. Cancer Research, 68, 6092-6099.
7. Staroselsky, A. H., Pathak, S., Chernajovsky, Y., Tucker, S. L., & Fidler, I. J. (1991). Predominance of the metastatic phenotype in somatic cell hybrids of the K-1735 murine melanoma. Cancer Research, 51, 6292-6298.
8. Tischoff, I., & Tannapfel, A. (2007). Pathologic and anatomic evidence of peritoneal metastases. Chirurg, 78, 1085-1090.
9. Finkelstein, S. D., Sayegh, R., Christensen, S., & Swalsky, P. A. (1993). Genotypic classification of colorectal adenocarcinoma. Cancer, 71, 3827-3838.
10. Morton, J. P., Timpson, P., Karim, S. A., Ridgway, R. A., Athineos, D., Doyle, B., et al. (2010). Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer. PNAS, 107, 246-251.
11. Lee,K. E., Lee,H.-J., Kim,Y. H., Yu,H. J.,Yang, H.-K., Kim,W.-H., et al. (2003). Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer. Japanese Journal of Clinical Oncology, 33, 173-179. (Pubitemid 43102860)
12. Guilford, P., Hopkins, J., Harraway, J., McLeod, M., McLeod, N., Harawira, P., et al. (1998). E-cadherin germline mutations in familial gastric cancer. Nature, 392, 402-405. (Pubitemid 28168738)
13. Richards, F. M., McKee, S. A., Rajpar, M. H., Cole, T. R., Evans, D. G., Jankowski, J. A., et al. (1999). Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Human Molecular Genetics, 8, 607-610. (Pubitemid 29139974)
14. Sadahiro, S., Suzuki, T., Maeda, Y., Tanaka, A., Makuuchi, H., Kamijo, A., et al. (2009). Prognostic factors in patients with synchronous peritoneal carcinomatosis (PC) caused by a primary cancer of the colon. Journal of Gastrointestinal Surgery, 13, 1593-1598.
15. Kowalski, P. J., Rubin, M. A., & Kleer, C. G. (2003). E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Research, 5, R217-R222.
16. Moll, R., Mitze, M., Frixen, U. H., & Birchmeier, W. (1993). Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. American Journal of Pathology, 143, 1731-1742. (Pubitemid 24058276)
17. Amado, R. G., Wolf, M., Peeters, M., Van Cutsem, E., Siena, S., Freeman, D. J., et al. (2008). Wild-type Kras is required for panitumumab efficacy in patients with metastatic colorectal cancer. Journal of Clinical Oncology, 26, 1626-1634.
18. Rubin, B. P., Singer, S., Tsao, C., Duensing, A., Lux, M. L., Ruiz, R., et al. (2001). KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Research, 61, 8118-8121. (Pubitemid 33091601)
19. V12 and scribbled clones induces tumour growth and invasion. Nature, 463, 545-548.
20. Eder, M. (1984). Metastasis, facts and problems in human pathology. Verhandlungen der Deutschen Gesellschaft für Pathologie, 68, 1-11.
21. Acs, G., Lawton, T. J., Rebbeck, T. R., LiVolsi, V. A., & Zhang, P. J. (2001). Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. American Journal of Clinical Pathology, 115, 85-98. (Pubitemid 33695094)
22. Singer, S., Rubin, B. P., Lux, M. L., Chen, C.-J., Demetri, G. D., Fletcher, C. D. M., et al. (2002). Prognostic value of kit mutation type, mitotic activity, and histologic subtype in Gastrointestinal Stromal Tumors. Journal of Clinical Oncology, 20, 3898-3905.
23. Wilmanns, C., Eggstein, S., & Ruf, G. (2007). Score prediction of metastatic risk in gastrointestinal stromal tumours (GIST). Zentralblatt für Chirurgie, 132, 509-514.
24. Wilmanns, C., Steinhauer, S., Grossmann, J., & Ruf, G. (2009). Site-dependent differences in clinical, pathohistological, and molecular parameters in metastatic colon cancer. International Journal of Biological Sciences, 5, 458-465.
25. Nordlinger, B., Guiguet, M., Vaillant, J.-C., Balladur, P., Boudjeme, K., Bachallier, P., et al. (1996). Surgical resection of colorectal carcinoma metastases to the liver. Cancer, 77, 1254-1262.
26. Fong, Y., Fortner, J., Sun, R. L., Brennan, M. F., & Blumgart, L. H. (1999). Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer. Annals of Surgery, 230, 309-321. (Pubitemid 30191861)
27. Lennon, A. M., Mulcahy, H. E., Hyland, J. M. P., Lowry, C., White, A., Fennelly, D., et al. (2003). Peritoneal involvement in stage II colon cancer. American Journal of Clinical Pathology, 119, 108-113. (Pubitemid 37047904)
28. Guerrero, S., Casanova, I., Farré, L., Mazo, A., Capellà, G., & Mangues, R. (2000). K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression. Cancer Research, 60, 6750-6756.
29. Jou, T.-S., & Nelson, W. J. (1998). Effects of regulated expression of mutant rhoA and rac1 small GTPases on the development of epithelial (MDCK) cell polarity. The Journal of Cell Biology, 142, 85-100. (Pubitemid 28341142)
30. Christofori, G., & Semb, H. (1999). The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends in Biochemical Sciences, 24, 73-76. (Pubitemid 29346577)
31. Franquemont, D. W. (1995). Differentiation and risk assessment of gastrointestinal stromal tumors. American Journal of Clinical Pathology, 103, 41-47.
32. Carro, M. S., Lim, W. K., Alvarez, M. J., Bollo, R. J., Zhao, X., Snyder, E. Y., et al. (2010). The transcriptional network for mesenchymal transformation of brain tumours. Nature, 463, 318-325.
33. Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., et al. (2006). The consensus coding sequences of human breast and colorectal cancers. Science, 314, 268-274. (Pubitemid 44571966)
34. Pratt, C. H., Vadigepalli, R., Chakravarthula, P., Gonye, G. E., Philp, N. J., & Grunwald, G. B. (2008). Transcriptional regulatory network analysis during epithelial-mesenchymal transformation of retinal pigment epithelium. Molecular Vision, 14, 1414-1428.
35. Baugher, P. J., Krishnamoorthy, L., Price, J. E., & Dharmawardhane, S. F. (2005). Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells. Breast Cancer Research, 7, R965-R974.
36. Hall, A. (1998). Rho GTPases and the actin cytoskeleton. Science, 279, 509-514.
37. Smith, K. J., Levy, D. B., Maupin, P., Pollard, T. D., Vogelstein, B., & Kinzler, K. W. (1994). Wild-type but not mutant APC associates with the microtubule cytoskeleton. Cancer Research, 54, 3672-3675. (Pubitemid 24241176)
38. Munemitsu, S., Souza, B., Müller, O., Albert, I., Rubinfeld, B., & Polakis, P. (1994). The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Research, 54, 3676-3681. (Pubitemid 24241177)
39. Safina, A. F., Varga, A. E., Bianchi, A., Zheng, Q., Kunnev, D., Liang, P., et al. (2009). Ras alters epithelial-mesenchymal transition in response to TGFβ by reducing actin fibers and cell-matrix adhesion. Cell Cycle, 8, 284-298.
40. Scaltriti, M., & Baselga, J. (2006). The epidermal growth factor receptor pathway: a model for targeted therapy. Clinical Cancer Research, 12, 5268-5272. (Pubitemid 44497237)
41. August, D. A., Ottow, R. T., & Sugerbaker, P. H. (1984). Clinical perspective of human colorectal cancer metastasis. Cancer and Metastasis Reviews, 3, 303-324.
42. Loupakis, F., Pollina, L., Stasi, I., Ruzzo, A., Scartozzi, M., Santini, D., et al. (2009). PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancer. Journal of Clinical Oncology, 27, 2622-2629.
43. Baker, S. J., Fearon, E. R., Nigro, J. M., Hamilton, S. R., Preisinger, A. C., Jessup, J.M., et al. (1989). Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science, 244, 217-221. (Pubitemid 19110302)
44. Anthony, T., George, R., Rodriguez-Bigas, M., & Petrelli, N. J. (1996). Primary signet-ring cell carcinoma of the colon and rectum. Annals of Surgical Oncology, 3, 344-348. (Pubitemid 126729516)
45. Kern, S. E., Fearon, E. R., Tersmette, K. W. F., Enterline, J. P., Leppert, M., Nakamura, Y., et al. (1989). Allelic loss in colorectal carcinoma. Journal of the American Medical Association, 261, 3099-3103. (Pubitemid 19133351)
46. Goi, T., Yamaguchi, A., Nakagawara, G., Urano, T., Shiku, H., & Furukawa, K. (1998). Reduced expression of deleted colorectal carcinoma (DCC) protein in established colon cancers. British Journal of Cancer, 77, 466-471. (Pubitemid 28044053)
47. Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., et al. (2002). Mutations of the BRAF gene in human cancer. Nature, 417, 949-954. (Pubitemid 34716871)
48. Artale, S., Sartore-Bianchi, A., Veronese, S.M., Gambi, V., Sarnataro, C. S., Cambacorta, M., et al. (2008).Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer. Journal of Clinical Oncology, 26, 4217-4219.
49. Grille, S. J., Bellacosa, A., Upson, J., Klein-Szanto, A. J., van Roy, F., Lee-Kwon, W., et al. (2003). The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Research, 63, 2172-2178. (Pubitemid 36538623)
50. Zeisberg, M., Shah, A. A., & Kalluri, R. (2005). Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. Journal of Biological Chemistry, 280, 8094-8100. (Pubitemid 40349708)
51. Samuels, Y., Diaz, L. A., Schmidt-Kittler, O., Cummins, J. M., DeLong, L., Cheong, I., et al. (2005). Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell, 7, 561-573. (Pubitemid 40799249)
52. Ogino, S., Nosho, K., Kirkner, G. J., Shima, K., Irahara, N., Kure, S., et al. (2009). PIK3CA mutation is associated with poor prognosis among patiens with curatively resected colon cancer. Journal of Clinical Oncology, 27, 1477-1484.
53. Wee, S., Jagani, Z., Xiang, K. X., Loo, A., Dorsch, M., Yao, Y.-M., et al. (2009). PI3K pathway activation mediates resistance to MEK inhibitors in KRAS mutant cancers. Cancer Research, 69, 4286-4293.
54. Sanders, K. M., & Ward, S. M. (2006). Interstitial cells of Cajal: a new perspective on smooth muscle function. Journal of Physiology, 576, 721-726. (Pubitemid 44637878)
55. Fletcher, C. D. M., Berman, J. J., Corless, C., Gorstein, F., Lasota, J., Longley, B. J., et al. (2002). Diagnosis of gastrointestinal stromal tumors: a consensus approach. Human Pathology, 33, 459-465. (Pubitemid 34747864)
56. Yarden, Y., Escobedo, J. A., Kuang, W.-J., Yang-Feng, T. L., Daniel, T. O., Tremble, P. M., et al. (1986). Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors. Nature, 323, 226-232. (Pubitemid 16054308)
57. DeMatteo, R. P., Heinrich, M. C., El-Rifai, W. M., & Demetri, G. (2002). Clinical management of gastrointestinal stromal tumors: before and after STI-571. Human Pathology, 33, 466-477. (Pubitemid 34747865)
58. Sattler, M., Salgia, R., Shrikhande, G., Verma, S., Pisick, E., Prasad, K. V. S., et al. (1997). Steel factor induces tyrosine phosphorylation of CRKL and binding of CRKL to a complex containing c-kit, phosphatidylinositol 3-kinase, and p120CBL. Journal of Biological Chemistry, 272, 10248-10253. (Pubitemid 27171705)
59. Yang, J., Du, X., Lazar, A. J. F., Pollock, R., Hunt, K., Chen, K., et al. (2008). Genetic aberrations of gastrointestinal stromal tumors. Cancer, 113, 1532-1543.
60. Agaimy, A., Pelz, A.-F., Corless, C. L., Wünsch, P. H., Heinrich, M. C., Hofstaedter, F., et al. (2007). Epitheloid gastric stromal tumours of the antrum in young females with the Carney triad: a report of three new cases with mutational analysis and comparative genomic hybridization. Oncology Reports, 18, 9-15.
61. Sakamoto, K., Sakurai, S., Kanda, T., Sakuma, Y., Hishima, T., Hironaka, M., et al. (2010). Pleomorphic phenotypes of gastrointestinal stromal tumors at metastatic sites with or without imatinib treatment. Cancer Science, 101, 1270-1278.
62. Shimoyama, Y.,Hirohashi, S., Hirano, S.,Noguchi, M., Shimosato, Y., Takeichi,M., et al. (1989). Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Research, 49, 2128-2133. (Pubitemid 19106526)
63. 2+-dependent cell adhesion molecule expressed in liver and intestine. The Journal of Cell Biology, 125, 1353-1369.
64. Becker, K.-F., Atkinson, M. J., Reich, U., Becker, I., Nekarda, H., Siewert, J. R., et al. (1994). E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Research, 54, 3845-3852. (Pubitemid 24241205)
65. Tamura, G., Yin, J., Wang, S., Fleisher, A. S., Zou, T., Abraham, J. M., et al. (2000). E-cadherin gene promoter hypermethylation in primary human gastric carcinomas. Journal of the National Cancer Institute, 92, 569-573. (Pubitemid 30212319)
66. Mayer, B., Johnson, J. P., Leitl, F., Jauch, K. W., Heiss, M. M., Schildberg, F. W., et al. (1993). E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Research, 53, 1690-1695. (Pubitemid 23113253)
67. Steeg, P. S., Horak, C. E., & Miller, K. D. (2008). Clinical-translational approaches to the nm23-H1 metastasis suppressor. Clinical Cancer Research, 14, 5006-5012.
68. Douma, S., van Laar, T., Zevenhoven, J., Meuwissen, R., van Garderen, E., & Peeper, D. S. (2004). Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature, 430, 1034-1040. (Pubitemid 39128389)
69. Yu, Y., Zhang, S., Wang, X., Yang, Z., & Ou, G. (2010). Over-expression of TrkB promotes the progression of colon cancer. APMIS, 118, 188-195.
70. Kalluri, R., & Weinberg, R. A. (2009). The basics of epithelial-mesenchymal transition. The Journal of Clinical Investigation, 119, 1420-1428.
71. Bissell, M. J., Radisky, D. C., Rizki, A.,Weaver, V. M., & Peterson, O.W. (2002). The organizing principle: microenvironmental influences in the normal and malignang breast. Differentiation, 70, 537-546. (Pubitemid 36194318)